Share of the population living with HIV receiving antiretroviral therapy in Malaysia

Malaysia: Share of the population living with HIV receiving antiretroviral therapy was 60.4% in 2024. ◆ Volatile

Latest (2024)
60.4%
Change on year
up 3.8%
World rank
110th
of 149 countries
All-time high
60.4%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Malaysia, 1990–2024

02040601990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0.121 %1999: 0.156 %2000: 0.256 %2001: 1.9 %2002: 4.3 %2003: 6.4 %2004: 8.5 %2005: 10.4 %2006: 12.1 %2007: 13.8 %2008: 15.3 %2009: 16.6 %2010: 18 %2011: 19.4 %2012: 19.8 %2013: 22.5 %2014: 27.8 %2015: 32.6 %2016: 45.1 %2017: 48.5 %2018: 50.9 %2019: 53.9 %2020: 56.9 %2021: 56.6 %2022: 56.4 %2023: 58.2 %2024: 60.4 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

Malaysia recorded 60.4% for share of the population living with hiv receiving antiretroviral therapy in 2024. That is the highest value across all 35 years on record.

Compared with earlier readings it is up 3.8% on the previous year and up 117.5% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Malaysia peaked at 60.4% in 2024 and was at its lowest, 0.0%, in 1990.

Malaysia ranks 110th of 149 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Malaysia, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Malaysia, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.1% —
1999 0.2% +28.6%
2000 0.3% +64.6%
2001 1.9% +661.1%
2002 4.3% +119.2%
2003 6.4% +50.9%
2004 8.5% +31.6%
2005 10.4% +22.3%
2006 12.1% +16.9%
2007 13.8% +13.4%
2008 15.3% +10.9%
2009 16.6% +9.2%
2010 18.0% +8.2%
2011 19.4% +7.8%
2012 19.8% +2.2%
2013 22.5% +13.5%
2014 27.8% +23.3%
2015 32.6% +17.4%
2016 45.1% +38.4%
2017 48.5% +7.4%
2018 50.9% +5.0%
2019 53.9% +5.8%
2020 56.9% +5.6%
2021 56.6% -0.6%
2022 56.4% -0.3%
2023 58.2% +3.2%
2024 60.4% +3.8%

Malaysia compared with similar countries

  • Malaysia's 60.4% is below the median for upper middle income countries, which is 65.5%, 92% of the median. (43 countries reporting)
  • Malaysia's 60.4% is below the median for East Asia & Pacific, which is 64.2%, 94% of the median. (15 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Malaysia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2001 +661.1% 0.3% 1.9%
2002 +119.2% 1.9% 4.3%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.2% 10
2000s 9.0% 0.3% 16.6% 10
2010s 33.9% 18.0% 53.9% 10
2020s 57.7% 56.4% 60.4% 5

Countries ranked near Malaysia

  1. 107 Saint Kitts and Nevis 61.1% compare
  2. 108 Montenegro 61.0% compare
  3. 109 East Timor 60.8% compare
  4. 111 Barbados 60.4% compare
  5. 112 Bolivia 59.7% compare
  6. 113 North Macedonia 59.1% compare

See the full ranking of 149 places →

More reference data data for Malaysia

All data for Malaysia →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Malaysia?
Share of the population living with hiv receiving antiretroviral therapy in Malaysia was 60.4% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Malaysia?
The highest recorded value was 60.4% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Malaysia?
The lowest recorded value was 0.0% in 1990.
How does Malaysia rank for share of the population living with hiv receiving antiretroviral therapy?
Malaysia ranks 110th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Malaysia?
Over the last ten years it is up 117.5%. The long-run trend across the full record is volatile.
Where does this Malaysia data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Malaysia. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/malaysia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/malaysia/">Share of the population living with HIV receiving antiretroviral therapy in Malaysia</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.